Home News

2018 full year results presentation

Operating income, growth figures, profitability and how our products have behaved.

Tue, 26/02/2019 - 11:15 0 min
Download related document
No votes yet
 
Related
ROVI announces the construction of a second heparin plant in Granada
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has announced the future construction of a new manufacturing plant for the active substance...
3 min
05/09/2019
First half 2019 results presentation
0 min
30/07/2019
ROVI increases its operating revenue by 21% and EBITDA by 99%
Operating revenue increased by 21% to 177.5 million euros in the first half of 2019, mainly driven by the strength of the specialty...
6 min
30/07/2019